Apellis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
APLS Key Statistics
Stock Snapshot
With a market cap of 3.46B, Apellis Pharmaceuticals(APLS) trades at $27.34. The stock has a price-to-earnings ratio of 91.95.
On 2026-01-11, Apellis Pharmaceuticals(APLS) stock traded between a low of $26.19 and a high of $27.44. Shares are currently priced at $27.34, which is +4.4% above the low and -0.4% below the high.
Apellis Pharmaceuticals(APLS) shares are trading with a volume of 4.01M, against a daily average of 2.34M.
In the last year, Apellis Pharmaceuticals(APLS) shares hit a 52-week high of $31.17 and a 52-week low of $16.10.
In the last year, Apellis Pharmaceuticals(APLS) shares hit a 52-week high of $31.17 and a 52-week low of $16.10.
APLS News
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity...
